Skip to content

Addiction: all studies

Page 253 of 855: studies 2,521 to 2,530 of 8,547, newest first. Back to the addiction overview

Research

The medical sociological and social epidemiological psychedelics paradigm (MSSEPP)

Drug Science, Policy and Law November 1, 2025 S. Viña

Although psychedelics have shown therapeutic potential in treating conditions such as depression, PTSD, and addiction, concerns remain regarding ethical practices, participant diversity, and the structural limitations of prevailing theoretical frameworks. This theoretical framework critically examines the dominant biopsychic model that underpins much of contemporary psychedelic research and...

The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.

Pharmacology, Biochemistry, and Behavior November 1, 2025 Shadan Rahmani, Rachel Crupi, Anthony L Riley et al.

After many years of stigma and neglect, there is a resurgence of interest in the therapeutic use of psychedelic drugs. Anecdotal and evidence-based reports indicate psychedelics as a possible treatment for depression, anxiety, PTSD, substance abuse, and other disorders resistant to conventional medical interventions. The available data, however, are limited and the use of psychedelic substances...

Development of a physiologically based pharmacokinetic model of N,N-dimethyltryptamine, harmine, and their interactions from ayahuasca in rats and humans.

Toxicological sciences : an official journal of the Society of Toxicology November 1, 2025 Naphat Wittayakarn, Yu-Mei Tan, Pattanachai Choomalaiwong et al.

Ayahuasca is a traditional Amazonian brew composed of Psychotria viridis, containing N,N-dimethyltryptamine (DMT), and Banisteriopsis caapi, which includes harmala alkaloids such as harmine. Ayahuasca can produce potent psychoactive effects primarily due to DMT, whose metabolism is inhibited by harmine via monoamine oxidase-A enzymes. This inhibition increases DMT's systemic bioavailability,...

DOI: 10.1093/toxsci/kfaf118 (opens in new tab) Full text (opens in new tab) Ayahuasca Banisteriopsis caapi Psychotria viridis N,N-Dimethyltryptamine +2

Terapias psicodélicas (psilocibina, mdma) en el tratamiento del trastorno de estrés postraumático

Polo del Conocimiento November 1, 2025 Jhon Bryan Paca Aucancela

El Trastorno de Estrés Postraumático (TEPT) constituye un desafío clínico significativo debido a las altas tasas de resistencia a la farmacoterapia convencional y el abandono de las terapias tradicionales. Ante este escenario, el actual "renacimiento psicodélico" propone el uso controlado de sustancias psicoactivas como herramientas para potenciar el procesamiento del trauma. El objetivo de...

CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS

Neuro-Oncology November 1, 2025 Richard Drexler, Belgin Yalçın, Rebecca Mancusi et al.

Abstract High-grade gliomas are the most aggressive form of brain tumors, and neuronal activity has emerged as a driver of glioma pathophysiology. Activity-dependent glioma growth results from paracrine factor signaling and bona fide neuron-to-glioma synapses that integrate glioma cells into brain-wide neuronal circuits. Here, we report how glioma cells integrate into serotonergic (5-HT)...

The Relationship Between Psychedelic Use and Positive Adult Development in Emerging Adulthood: An Integrative Review.

Brain and Behavior November 1, 2025 Jake Payne, Oliver Robinson, Kevin O. St. Arnaud et al. 3 citations

Preliminary evidence suggests that classic psychedelics may exert lasting positive effects on individuals' mood, cognition, and personality, but little is known about how these effects may differ across the lifespan. Emerging adulthood (18-29) is a critical developmental stage in which individuals transition from dependence on community institutions toward full independence. It is a time when...

DOI: 10.1002/brb3.71043 (opens in new tab) Full text (opens in new tab) Psychedelics Personal growth Emerging adulthood Well-being

Peace and the Unconditioned: Nibbāna as the Supreme Pacification

International Journal For Multidisciplinary Research October 31, 2025 Vivek Kumar

Abstract This article argues that early Buddhist discourse in the Sutta Piṭaka construes peace not as mere emotional calm or social quietism but as the pacification (upasama) that culminates in nibbāna, the unconditioned. Reading key formulae “nibbānaṁ paramaṁ sukhaṁ,” “stilling of all formations” (sabbasaṅkhārasamatho), and epithets such as santi (peace) and khema (security) the study...

PSYCHEDELICS AND ENTACTOGENS IN PSYCHIATRY: PHARMACOLOGY, CLINICAL TRIAL EVIDENCE, AND REGULATORY CONSIDERATIONS

Global Journal of Research in Biology and Pharmacy October 31, 2025 Ifeyinwa Adar Opoku

Psychedelics, including psilocybin, lysergic acid diethylamide, and dimethyltryptamine, and entactogens such as 3,4-methylenedioxymethamphetamine are being investigated for treatment-resistant depression, post-traumatic stress disorder, anxiety, and substance use disorders. These compounds act primarily through serotonin 5-HT2A receptor agonism (psychedelics) or monoamine release (MDMA),...

Role of mycelia derived from in vitro cultures of Amanita spp. as a potential source of bioactive compounds with therapeutic potential for the mitigation and management of depressive disorders.

Psychiatria Polska October 31, 2025 Katarzyna Kała, Katarzyna Sułkowska‐ziaja, Joanna Piotrowska et al.

Mushrooms of the Amanita genus are considered among the most toxic, causing severe poisoning, often resulting in death. However, of the 707 described species within this genus, only around a dozen contain the toxic octapeptides classified as amanitotoxins and phallotoxins. While most representatives of the genus are considered inedible species, there are a few exceptions that are palatable...